SCHEMBL7246808

SCHEMBL7246808

CCOC(=O)c1sc(Oc2ccc(OC)c(OC)c2)c2c1CCC(=CN(C)C)C2=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.36
ALDH1A1 P00352 8/20 0.36
HSD17B10 Q99714 4/20 0.36
HPGD P15428 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALOX15 P16050 2/20 0.36
KDM4E B2RXH2 8/20 0.35
NPSR1 Q6W5P4 4/20 0.35
PPARG P37231 1/20 0.35
NCOA2 Q15596 1/20 0.35
NCOA1 Q15788 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
LMNA P02545 4/20 0.35
TP53 P04637 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ESR1 P03372 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7246805 1.00 MAPT (0.36) MAPTALDH1A1HSD17B10HPGDMEN1
SCHEMBL7247572 0.89 FNTA (0.38) MAPTALDH1A1HSD17B10HPGDMEN1
SCHEMBL7247569 0.89 FNTA (0.38) MAPTALDH1A1HSD17B10HPGDMEN1
SCHEMBL7242060 0.81 NPSR1 (0.52) MAPTALDH1A1HSD17B10HPGDMEN1
SCHEMBL7251146 0.77 ALDH1A1 (0.38) MAPTALDH1A1HSD17B10HPGDMEN1
SCHEMBL7245561 0.75 CCNC (0.55) MAPTALDH1A1HSD17B10HPGDMEN1
SCHEMBL7251113 0.75 MEN1 (0.38) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL7251115 0.75 MEN1 (0.38) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL25625606 0.75 MEN1 (0.42) MAPTALDH1A1HSD17B10MEN1KMT2A
SCHEMBL7243976 0.74 OGA (0.37) MAPTALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030158245-A1 Fused heterocyclic derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158245-A1 Fused heterocyclic derivatives, their production and use TST, STS, AHR MAPT 4852/4885ALDH1A1 327/4885HSD17B10 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.